Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
5.92
+0.01 (0.17%)
At close: Jul 3, 2025, 1:00 PM
6.23
+0.31 (5.24%)
After-hours: Jul 3, 2025, 4:11 PM EDT
Bolt Biotherapeutics Market Cap
Bolt Biotherapeutics has a market cap or net worth of $11.35 million as of July 3, 2025. Its market cap has decreased by -60.51% in one year.
Market Cap
11.35M
Enterprise Value
-2.78M
1-Year Change
-60.51%
Ranking
Category
Stock Price
$5.92
Market Cap Chart
Since the IPO on February 5, 2021, Bolt Biotherapeutics's market cap has decreased from $690.43M to $11.35M, a decrease of -98.36%. That is a compound annual growth rate of -60.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 11.35M | -44.59% |
| Dec 31, 2024 | 20.48M | -51.84% |
| Dec 29, 2023 | 42.52M | -13.15% |
| Dec 30, 2022 | 48.96M | -73.20% |
| Dec 31, 2021 | 182.69M | -73.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 699.61B |
| Johnson & Johnson | 375.83B |
| AbbVie | 335.46B |
| Novo Nordisk | 309.43B |
| UnitedHealth Group | 281.10B |
| Novartis AG | 243.28B |
| Abbott Laboratories | 233.26B |
| AstraZeneca | 219.33B |